Clinical meaning
Graves' disease is the most common cause of hyperthyroidism, caused by thyroid-stimulating immunoglobulins (TSI) — IgG autoantibodies that bind to and activate the TSH receptor on thyroid follicular cells. Unlike TSH, which is regulated by negative feedback, TSI stimulates the thyroid gland continuously and independently, leading to unregulated synthesis and secretion of thyroid hormones (T3 and T4). Excess thyroid hormones increase cellular metabolic rate by upregulating Na+/K+-ATPase activity and uncoupling oxidative phosphorylation, resulting in heat intolerance, weight loss despite increased appetite, tachycardia, and tremor. Thyroid hormones also increase beta-adrenergic receptor sensitivity, amplifying sympathetic nervous system effects on the cardiovascular system. Graves' ophthalmopathy results from TSI cross-reacting with TSH receptors on orbital fibroblasts, triggering inflammation, glycosaminoglycan deposition, and edema of extraocular muscles and retroorbital tissue — producing exophthalmos. Pretibial myxedema (dermopathy) occurs through a similar mechanism in skin fibroblasts.